Citation Impact
Citing Papers
Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
2010
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
2012
Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations
2010
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Full and Broad-Spectrum In Vivo Eradication of Catheter-Associated Biofilms Using Gentamicin-EDTA Antibiotic Lock Therapy
2012
Directed Evolution Mimics Allosteric Activation by Stepwise Tuning of the Conformational Ensemble
2018 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Fosfomycin
2016
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit
2009
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy
2011
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
2014
Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration
2013
Molecular mechanisms of antibiotic resistance
2014 Standout
Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections
2013
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
2016
New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus
2009
A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis
2013
Marine natural products
1990 Standout
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Vancomycin resistance in Staphylococcus aureus
2004
Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo
2012 Standout
Mechanism of Action and Resistance to Daptomycin inStaphylococcus aureusand Enterococci
2016
Tigecycline Use in Cancer Patients With Serious Infections
2009
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus
2016
Recent developments for Staphylococcus aureus vaccines: clinical and basic science challenges
2015
Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions
2009
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Antibacterial and bioactive composite bone cements containing surface silver-doped glass particles
2015
The Science of Antibiotic Discovery
2020 Standout
Daptomycin Versus Vancomycin for Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus With a High Vancomycin Minimum Inhibitory Concentration: A Case-Control Study
2011
Intracellular Staphylococcus aureus in bone and joint infections: A mechanism of disease recurrence, inflammation, and bone and cartilage destruction
2020
Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies
2013
Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections
2010
Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
2016 StandoutNobel
Biofilm Antimicrobial Susceptibility Increases With Antimicrobial Exposure Time
2016
Genomic and Functional Characterization of Enterococcus faecalis Isolates Recovered From the International Space Station and Their Potential for Pathogenicity
2021 StandoutNobel
A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection
2012
Polysaccharide intercellular adhesin in biofilm: structural and regulatory aspects
2015
Identification of novel cyclic lipopeptides from a positional scanning combinatorial library with enhanced antibacterial and antibiofilm activities
2015
Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review
2013 Standout
Organocatalytic umpolung: N-heterocyclic carbenes and beyond
2012 Standout
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Plasma HSPA12B Is a Potential Predictor for Poor Outcome in Severe Sepsis
2014
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management
2015
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Succession and persistence of microbial communities and antimicrobial resistance genes associated with International Space Station environmental surfaces
2018
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections
2010
Novel Bacterial Metabolite Merochlorin A Demonstrates in vitro Activity against Multi-Drug Resistant Methicillin-Resistant Staphylococcus aureus
2012
In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin
2010
Clinical management of Staphylococcus aureus bacteraemia
2011
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Where does a Staphylococcus aureus vaccine stand?
2014
Humanized Mice Exhibit Exacerbated Abscess Formation and Osteolysis During the Establishment of Implant-Associated Staphylococcus aureus Osteomyelitis
2021
IsdB antibody–mediated sepsis following S. aureus surgical site infection
2020
A Comprehensive View on the Human Antibody Repertoire Against Staphylococcus aureus Antigens in the General Population
2021
The epidemiology of antibiotic resistance
2008
New approaches for treating staphylococcal biofilm infections
2011
The antimicrobial activity of nanoparticles: present situation and prospects for the future
2017 Standout
Optimizing combination rifampin therapy for staphylococcal osteoarticular infections
2013
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Vertebral Osteomyelitis Cases Complicated by Bacteremia Treated with High-Dose Daptomycin and Trimethoprim-Sulfamethoxazole
2012
Mobile Genetic Elements Associated with Antimicrobial Resistance
2018 Standout
Antibiotic tolerance and the alternative lifestyles of Staphylococcus aureus
2017
Lack of Humoral Immunity Against Glucosaminidase Is Associated with Postoperative Complications in Staphylococcus aureus Osteomyelitis
2020
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
2020 Standout
NHC-catalysed, chemoselective crossed-acyloin reactions
2011
Multicenter Evaluation of the Clinical Outcomes of Daptomycin with and without Concomitant β-Lactams in Patients with Staphylococcus aureus Bacteremia and Mild to Moderate Renal Impairment
2012
Engineered Biosynthesis of β‐Alkyl Tryptophan Analogues
2018 StandoutNobel
Serum antibodies against Staphylococcus aureus can prognose treatment success in patients with bone infections
2020
Whole-Genome Analyses of Enterococcus faecium Isolates with Diverse Daptomycin MICs
2014
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Adaptation of Enterococcus faecalis to Daptomycin Reveals an Ordered Progression to Resistance
2013
Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA
2013
Activities of Daptomycin and Vancomycin Alone and in Combination with Rifampin and Gentamicin against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Isolates in an Experimental Model of Endocarditis
2009
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
High-Dose Daptomycin Therapy for Left-Sided Infective Endocarditis: a Prospective Study from the International Collaboration on Endocarditis
2013
New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis
2021
Relationship between Susceptibility to Daptomycin In Vitro and Activity In Vivo in a Rabbit Model of Aortic Valve Endocarditis
2009
Biochemical Characterization of Cardiolipin Synthase Mutations Associated with Daptomycin Resistance in Enterococci
2012
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Daptomycin: The role of high-dose and combination therapy for Gram-positive infections
2013
Vancomycin Resistance in Staphylococcus aureus
.
2017
Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes
2017
Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]‐Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE
2016 StandoutNobel
Update on Human Rhinovirus and Coronavirus Infections
2016
Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy
2014
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Organocatalytic Reactions Enabled by N-Heterocyclic Carbenes
2015 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus
2009
Efficacy of High Doses of Daptomycin versus Alternative Therapies against Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus
2009
Efficacy of Usual and High Doses of Daptomycin in Combination with Rifampin versus Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus
2010
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Treatment of High-Level Gentamicin-Resistant Enterococcus faecalis Endocarditis with Daptomycin plus Ceftaroline
2013
Role of Rifampin against Staphylococcal Biofilm Infections In Vitro , in Animal Models, and in Orthopedic-Device-Related Infections
2018
Effect of tolerance on the evolution of antibiotic resistance under drug combinations
2020 Science
Predictors of Mortality in Staphylococcus aureus Bacteremia
2012
Mechanisms of vancomycin resistance in Staphylococcus aureus
2014
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Daptomycin-Oxacillin Combinations in Treatment of Experimental Endocarditis Caused by Daptomycin-Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus with Evolving Oxacillin Susceptibility (the “Seesaw Effect”)
2010
Prosthetic Joint Infection
2014 Standout
An Engineered Tryptophan Synthase Opens New Enzymatic Pathways to β‐Methyltryptophan and Derivatives
2016
Evaluation of Standard- and High-Dose Daptomycin versus Linezolid against Vancomycin-Resistant Enterococcus Isolates in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations
2012
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Silver Nanoparticles as Potential Antibacterial Agents
2015
Redox-active nanomaterials for nanomedicine applications
2017
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections
2013
Works of Warren E. Rose being referenced
Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
2019
Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
2019
Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
2012
Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline
2014
Alternative Mutational Pathways to Intermediate Resistance to Vancomycin in Methicillin-Resistant Staphylococcus aureus
2013
Elevated Serum Interleukin-10 at Time of Hospital Admission Is Predictive of Mortality in Patients With Staphylococcus aureus Bacteremia
2012
Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus
2008
Tigecycline: First of a New Class of Antimicrobial Agents
2006
Daptomycin versus Vancomycin for Complicated Skin and Skin Structure Infections: Clinical and Economic Outcomes
2007
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study
2010
Is virus coinfection a predictor of severity in children with viral respiratory infections?
2014
Concentration-dependent effects of antimicrobials on Staphylococcus aureus toxin-mediated cytokine production from peripheral blood mononuclear cells
2011
Mechanical, material, and antimicrobial properties of acrylic bone cement impregnated with silver nanoparticles
2014
Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic model
2008
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies
2007
Invasive community-associated MRSA infections: epidemiology and antimicrobial management
2010
Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function
2007
Daptomycin Activity against Staphylococcus aureus following Vancomycin Exposure in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations
2007
Fosfomycin Synergy In Vitro with Amoxicillin, Daptomycin, and Linezolid against Vancomycin-Resistant Enterococcus faecium from Renal Transplant Patients with Infected Urinary Stents
2012
β-Lactam Antibiotics Targeting PBP1 Selectively Enhance Daptomycin Activity against Methicillin-Resistant Staphylococcus aureus
2013
Evaluation of Telavancin Alone and Combined with Ceftaroline or Rifampin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Biofilm Model
2018
Defining Daptomycin Resistance Prevention Exposures in Vancomycin-Resistant Enterococcus faecium and E. faecalis
2014
Genotypic and Phenotypic Evaluation of the Evolution of High-Level Daptomycin Nonsusceptibility in Vancomycin-Resistant Enterococcus faecium
2012
Addition of Ceftaroline to Daptomycin after Emergence of Daptomycin-Nonsusceptible Staphylococcus aureus during Therapy Improves Antibacterial Activity
2012
Multiple‐Dose Oritavancin Evaluation in a Retrospective Cohort of Patients with Complicated Infections
2017
Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium
2013
Vancomycin Tolerance in Methicillin-Resistant Staphylococcus aureus: Influence of Vancomycin, Daptomycin, and Telavancin on Differential Resistance Gene Expression
2012
Pharmacodynamics of a Simulated Single 1,200-Milligram Dose of Oritavancin in an In Vitro Pharmacokinetic/Pharmacodynamic Model of Methicillin-Resistant Staphylococcus aureus Infection
2012
Characterizing Vancomycin-Resistant Enterococcus Strains with Various Mechanisms of Daptomycin Resistance Developed in an In Vitro Pharmacokinetic/Pharmacodynamic Model
2011
Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities to Daptomycin in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations
2008
Simulated Antibiotic Exposures in an In Vitro Hollow-Fiber Infection Model Influence Toxin Gene Expression and Production in Community-Associated Methicillin-Resistant Staphylococcus aureus Strain MW2
2011
Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms
2019
Structure and Biosynthesis of the Antibiotic Bottromycin D
2012
Relationship of In Vitro Synergy and Treatment Outcome with Daptomycin plus Rifampin in Patients with Invasive Methicillin-Resistant Staphylococcus aureus Infections
2013
Activities of High-Dose Daptomycin, Vancomycin, and Moxifloxacin Alone or in Combination with Clarithromycin or Rifampin in a NovelIn VitroModel ofStaphylococcus aureusBiofilm
2010
Evaluation of Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus Developing Nonsusceptibility to Daptomycin
2007
Impact of Inoculum Size and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) on Vancomycin Activity and Emergence of VISA in an In Vitro Pharmacodynamic Model
2008
Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam–Daptomycin Synergy
2015
Heterogeneity of Genetic Pathways toward Daptomycin Nonsusceptibility in Staphylococcus aureus Determined by Adjunctive Antibiotics
2015